Apolipoprotein E is a Potential Biomarker for Predicting Cancer Prognosis and is Correlated with Immune Infiltration
DOI: https://doi.org/10.2147/ott.s447319
IF: 4
2024-03-19
OncoTargets and Therapy
Abstract:Jinji Chen, 1, &ast Herong Zhu, 2, &ast Shaohua Chen, 3 Hua Mi 1 1 Department of Urology, the First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, People's Republic of China; 2 Department of Urology, Guangdong Provincial Hospital of Integrated Traditional Chinese and Western Medicine, Foshan, People's Republic of China; 3 Department of Urology, Guangxi Medical University Cancer Hospital, Nanning, Guangxi Zhuang Autonomous Region, People's Republic of China &astThese authors contributed equally to this work Correspondence: Hua Mi Department of Urology, the First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, People's Republic of China , Email Shaohua Chen Department of Urology, Guangxi Medical University Cancer Hospital, Nanning, Guangxi Zhuang Autonomous Region, People's Republic of China , Email Background: Apolipoprotein E (APOE) is a polymorphic protein that plays a role in lipoprotein transformation and metabolism. It is involved in numerous physiological processes within the body and is closely associated with tumor growth and metastasis. However, the role of APOE in pan-cancer has yet to be evaluated. Therefore, studying the association between APOE and various cancer types is crucial for providing a basis for individualized treatment strategies and clinical prognosis assessment. Methods: We investigated the diagnostic and prognostic significance of APOE across 33 tumor types, as well as its correlation with tumor mutation burden (TMB) and microsatellite instability (MSI). Additionally, we employed the ESTIMATE and CIBERSORT algorithms to analyze the potential impact of APOE on the immune system. Furthermore, gene set enrichment analysis (GSEA) was conducted to explore its underlying physiological function. Results: Based on observations from a pan-cancer dataset, APOE expression was significantly different between cancer and normal tissues, and was simultaneously associated with survival outcomes in terms of cancer type, clinical annotation, TMB, MSI, and TICs abundance. In addition, the results also showed that expression of APOE may respond to a variety of cancer chemotherapy. Conclusion: The findings from this study strongly indicate a close association between APOE and tumor development. Moreover, APOE shows promise as a potential biomarker for predicting prognosis and response to immunotherapy in patients with pan-cancer. Keywords: apolipoprotein E, APOE, pan-cancer, prognosis, immune infiltration Cancer is the leading cause of premature death and reduced life expectancy in humans, imposing a significant burden on patients, their families, and society as a whole. 1 Immunotherapy with immune checkpoint blockade (ICB) has been a major breakthrough for cancer patients, but it is important to note that not all patients benefit from it. 2 Despite significant advancements in cancer research and management, there is still a need to explore better treatment options and strategies. 3 Furthermore, there is currently a lack of reliable biomarkers that can accurately predict the response to ICB therapy. 4 Therefore, there is an urgent need to study novel biomarkers that can be used to predict patient prognosis and monitor treatment responses, in order to advance personalized medicine and improve overall patient survival rates. APOE is a component of triglyceride-rich lipoproteins and is associated not only with various neurodegenerative diseases, including Alzheimer's and Parkinson's diseases, but also with evidence indicating its involvement in tumor progression and metastasis. 5–8 For example, previous studies have demonstrated that APOE enhances the proliferation and growth of papillary thyroid cancer cells by promoting cellular glycolysis. 9 Additionally, lung adenocarcinoma patients with malignant pleural effusion presenting with APOE over-expression had a shorter overall survival time. 10 The expression of APOE is essential for the growth and survival of ovarian cancer cells and high serum APOE level can be used to assist in the diagnosis of ovarian cancer. 11 In gastric cancer, tumor-associated macrophages (TAMs) promote tumor cell metastasis by releasing exosomes that secrete APOE, thereby activating the PI3K-Akt signaling pathway. 8 In prostate cancer, tumor cells promote senescence in TREM2+ immunosuppressive neutrophils through the secretion of APOE. 12 However, APOE has been shown to exert anti-tumor effects and fulfill an essential role in reversing the immune suppressive phenotypes in th -Abstract Truncated-
oncology,biotechnology & applied microbiology